Skip to content
CNS Clinical Research

Oklahoma

CNS clinical trials in Oklahoma

40 CNS studies are recruiting participants at sites in 5 cities across Oklahoma as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Oklahoma city with a recruiting study

By research area: Depression (18), Multiple Sclerosis (7), Parkinson's Disease (6), Migraine (4), Schizophrenia (4), Bipolar Disorder (1).

Oklahoma City (23), Tulsa (15), Edmond (8), Norman (2), Yukon (2).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Oklahoma

Basic details from each study's public record (the 12 most recently updated of 40). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Oklahoma City
    Registry record
    NCT07226661 · updated
  2. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Oklahoma City
    Registry record
    NCT06748222 · updated
  3. Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    Oklahoma City
    Registry record
    NCT06372964 · updated
  4. Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Edmond
    Registry record
    NCT06559306 · updated
  5. A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Edmond
    Registry record
    NCT07573176 · updated
  6. Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Recruiting in
    Edmond
    Registry record
    NCT06966401 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Oklahoma on ClinicalTrials.gov.

Schizophrenia: recently updated in Oklahoma

  1. Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    Norman
    Registry record
    NCT06229210 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Oklahoma on ClinicalTrials.gov.

Parkinson's disease: recently updated in Oklahoma

  1. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Oklahoma City · Tulsa
    Registry record
    NCT06952504 · updated
  2. A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Tulsa
    Registry record
    NCT07216703 · updated
  3. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    • Phase 3
    • Ages 50 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Tulsa
    Registry record
    NCT07174310 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Oklahoma on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Oklahoma

  1. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Oklahoma City
    Registry record
    NCT07299019 · updated
  2. Skeletal Muscle Aging and Responsiveness in Aged People With MS

    • No phase
    • Ages 60 and older
    • All sexes
    Sponsor
    Oklahoma Medical Research Foundation
    Recruiting in
    Oklahoma City
    Registry record
    NCT07500727 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Oklahoma on ClinicalTrials.gov.

Ask about studies in Oklahoma

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call